Women’s Health Center for Clinical Trials

Trouble Sleeping Due to Frequent Bathroom Trips?
If you are struggling with frequent nighttime urination symptoms, consider participating in Nocturia Clinical Research Trials near you! Revive Research Institute is conducting Clinical Trials for potential treatment of Nocturia to investigate the safety and efficacy of a non-invasive nighttime urinary management solution that may be able to help women suffering from frequent urination at night.

If you or any woman you know has been dealing with nighttime urinary incontinence, consider enrolling in Nocturnal Enuresis Clinical Trials in Michigan.

Participation in the clinical trial is completely free, and no insurance is required.

Trouble Sleeping Due to Menopause? 

If you are struggling with menopause symptoms and reduced quality of sleep, consider participating in Menopause Clinical Trials near you! Revive Research Institute is conducting Women’s Health Clinical Trials to investigate the safety and efficacy of an investigational drug that may be able to help women struggling with their sleep because of menopause.
Exploring these potential treatment options may help women find solutions to their sleep problems. Participation in the clinical trial is completely free, and no insurance is required.

Want to Heal from Your Bladder Pain?
Bladder Pain Syndrome Clinical Trials may be able to provide you with potential treatment options. Revive Research Institute is conducting a research study to investigate the safety and efficacy of an investigational oral drug that may be able to help women suffering from bladder pain and discomfort.

We’re looking for potential treatment options that could benefit women with living this condition. It can be inconvenient as well as embarrassing at times. Participation in the clinical trial is completely free, and no insurance is required.

Are you struggling with heavy menstrual bleeding?
Revive Research Institute is conducting Phase 3 Clinical Trials on contraceptive medications for sexually active women. We are enrolling females who constantly suffer from painful heavy bleeding due to uterine fibroids and endometriosis.

The purpose of this study is to evaluate if women using this drug for uterine fibroids and endometriosis could also use it as an oral contraceptive. Our research team at Revive’s Women’s Health Center is looking for ways to introduce the best line of innovative therapies for women with these conditions opting for birth control pills. Enrolled participants will be expected to take the medication once daily.

Think you might have a UTI?
A Urinary Tract Infection is never a pleasant experience. UTIs are unfortunately more frequent in women, due to their unique anatomy. The urethra tends to be relatively small and close to the anal opening therefore bladder infections are more prevalent in females.

Revive Research Institute’s Women’s Health Center is conducting Phase III clinical trials to assess the Safety and Efficacy of a study drug in treating Uncomplicated Urinary Tract Infections (Acute Cystitis).

Experiencing Hot Flashes?
Hot Flashes Clinical Trials may be able to provide you with potential treatment options. Revive Research Institute is conducting phase III research to study the safety and efficacy of a non-hormonal investigational drug that may be able to help postmenopausal women suffering from moderate to severe hot flashes (or vasomotor symptoms).

We’re looking to find potential treatment options that may help women suffering from this condition. It can cause hindrance and can be embarrassing at times as well. Participation in the clinical trial is completely free of cost and insurance is not required.

Have you recently noticed unfamiliar growth around your genital area?
Revive Research Institute is now enrolling participants in a research study that involves routine specimen collection from females who have been referred for a colposcopy based on routine cervical cancer screening.

The entire process of this one visit study will take only 45 to 60 minutes. After passing the eligibility criteria, the participant will have to give demographic and clinical history information. Furthermore, specimen samples will be taken and a colposcopy will be done. The purpose is to explore an investigational screening test for women potentially at high risk for HPV.